|
ZSCAN29 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81466999999991E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.6098999994506E-07 |
| Normal-vs-Stage2 |
1.538250E-02 |
| Normal-vs-Stage3 |
1.401690E-02 |
| Normal-vs-Stage4 |
2.064600E-01 |
| Stage1-vs-Stage2 |
4.834200E-01 |
| Stage1-vs-Stage3 |
3.950100E-02 |
| Stage1-vs-Stage4 |
4.677500E-03 |
| Stage2-vs-Stage3 |
4.608200E-01 |
| Stage2-vs-Stage4 |
1.479570E-01 |
| Stage3-vs-Stage4 |
3.395800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.00460000000713E-05 |
| Normal-vs-AfricanAmerican |
2.542200E-02 |
| Normal-vs-Asian |
3.47199999994885E-06 |
| Caucasian-vs-AfricanAmerican |
7.060400E-01 |
| Caucasian-vs-Asian |
2.441600E-02 |
| AfricanAmerican-vs-Asian |
1.432020E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.115270E-03 |
| Normal-vs-Female |
2.5570999995228E-07 |
| Male-vs-Female |
8.780700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.555160E-01 |
| Normal-vs-Age(41-60Yrs) |
2.84959999996559E-06 |
| Normal-vs-Age(61-80Yrs) |
3.634600E-04 |
| Normal-vs-Age(81-100Yrs) |
6.869200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.817200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.173000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.056400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.601800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.048200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.310400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.4220999995126E-07 |
| Normal-vs-Grade 2 |
2.83859999949954E-07 |
| Normal-vs-Grade 3 |
1.884420E-03 |
| Normal-vs-Grade 4 |
5.322000E-01 |
| Grade 1-vs-Grade 2 |
7.358100E-02 |
| Grade 1-vs-Grade 3 |
7.219500E-03 |
| Grade 1-vs-Grade 4 |
1.391290E-04 |
| Grade 2-vs-Grade 3 |
3.056500E-02 |
| Grade 2-vs-Grade 4 |
1.758240E-04 |
| Grade 3-vs-Grade 4 |
5.309900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.63179999804697E-09 |
| Normal-vs-ccB subtype |
9.138300E-03 |
| ccA subtype-vs-ccB subtype |
8.752000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.92259999999878E-05 |
| Normal-vs-N1 |
4.309400E-01 |
| N0-vs-N1 |
5.100000E-01 |
|
|
